Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation

Molecular Immunology

Volumn 52, Issue 3-4, 2012, Pages 207-216

  Tomasi, Maurizio ^a   Hiromasa, Yasuaki ^a   Pope, Michael R ^a   Gudlur, Sushanth ^a   Tomich, John M ^a   Fleming, Sherry D ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Apolipoprotein H; Ischemia; Mouse; Prostaglandin E2

Indexed keywords

AMINO ACID; ANTIBODY; ANTIGEN; BETA2 GLYCOPROTEIN 1; CARBOHYDRATE; COMPLEMENT; NEOANTIGEN; PROSTAGLANDIN E2; RECOMBINANT BETA2 GLYCOPROTEIN 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; ATTENUATION; BLOOD CHEMISTRY; BLOOD SAMPLING; CELL SURFACE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REPERFUSION INJURY; SEQUENCE HOMOLOGY; TISSUE INJURY;

AMINO ACID SEQUENCE; ANIMALS; BETA 2-GLYCOPROTEIN I; CELL MEMBRANE; DINOPROSTONE; HOMEODOMAIN PROTEINS; HUMANS; INFLAMMATION; INTESTINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN STRUCTURE, SECONDARY; PROTEOMICS; REPERFUSION INJURY; SEQUENCE ALIGNMENT;

EID: 84862726553     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.05.018     Document Type: Article

References (46)

1. Agar C., de Groot P.G., Marquart J.A., Meijers J.C. Evolutionary conservation of the lipopolysaccharide binding site of beta2-glycoprotein I. Thrombosis and Haemostasis 2011, 106:1069-1075.
2. Agar C., de Groot P.G., Morgelin M., Monk S.D., van Os G., Levels J.H., de Laat B., Urbanus R.T., Herwald H., van der Poll T., Meijers J.C. {beta}2-Glycoprotein I: a novel component of innate immunity. Blood 2011, 117:6939-6947.
3. Agar C., van Os G.M., Morgelin M., Sprenger R.R., Marquart J.A., Urbanus R.T., Derksen R.H., Meijers J.C., de Groot P.G. {beta}2-Glycoprotein I can exist in two conformations: implications for our understanding of the antiphospholipid syndrome. Blood 2010, 116:1336-1343.
4. Agostinis C., Biffi S., Garrovo C., Durigutto P., Lorenzon A., Bek A., Bulla R., Grossi C., Borghi M.O., Meroni P., Tedesco F. In vivo distribution of beta2 glycoprotein I under various pathophysiologic conditions. Blood 2011, 118:4231-4238.
5. Allen K.L., Fonseca F.V., Betapudi V., Willard B., Zhang J., McCrae K.R. A novel pathway for human endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 2011, 119:884-893.
6. Austen W.G., Kyriakides C., Favuzza J., Wang Y., Kobzik L., Moore F.D., Hechtman H.B. Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. Surgery 1999, 126:343-348.
7. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunology Today 1991, 12:154-159.
8. Balasubramanian K., Chandra J., Schroit A.J. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. Journal of Biological Chemistry 1997, 272:31113-31117.
9. Balasubramanian K., Maiti S.N., Schroit A.J. Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis. Apoptosis 2005, 10:439-446.
10. Bouma B., de Groot P.G., van den Elsen J.M., Ravelli R.B., Schouten A., Simmelink M.J., Derksen R.H., Kroon J., Gros P. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO Journal 1999, 18:5166-5174.
11. Buttari B., Profumo E., Mattei V., Siracusano A., Ortona E., Margutti P., Salvati B., Sorice M., Rigano R. Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood 2005, 106:3880-3887.
12. Cabiedes J., Cabral A.R., Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Journal of Rheumatology 1995, 22:1899-1906.
13. Chen J., Crispin J.C., Dalle Lucca J., Tsokos G.C. A novel inhibitor of the alternative pathway of complement attenuates intestinal ischemia/reperfusion-induced injury. Journal of Surgical Research 2009, 167:e131-e136.
14. Chiu C.-J., McArdle A.H., Brown R., Scott H.J., Gurd F.N. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Archives of Surgery 1970, 101:478-483.
15. Fischetti F., Durigutto P., Pellis V., Debeus A., Macor P., Bulla R., Bossi F., Ziller F., Sblattero D., Meroni P., Tedesco F. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood 2005, 106:2340-2346.
16. Fleming S.D., Egan R.P., Chai C., Girardi G., Holers V.M., Salmon J., Monestier M., Tsokos G.C. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. Journal of Immunology 2004, 173:7055-7061.
17. Fleming S.D., Pope M.R., Hoffman S.M., Moses T., Bukovnik U., Tomich J.M., Wagner L.M., Woods K.M. Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation. Journal of Immunology 2010, 185:6168-6178.
18. Fruchterman T.M., Spain D.A., Wilson M.A., Harris P.D., Garrison R.N. Complement inhbition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery 1998, 124:782-792.
19. Gries A., Nimpf J., Wurm H., Kostner G.M., Kenner T. Characterization of isoelectric subspecies of asialo-beta 2-glycoprotein I. Biochemical Journal 1989, 260:531-534.
20. Gropp K., Weber N., Reuter M., Micklisch S., Kopka I., Hallstrom T., Skerka C. beta-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator. Blood 2011, 118:2774-2783.
21. Hagihara Y., Hong D.P., Hoshino M., Enjyoji K., Kato H., Goto Y. Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids. Biochemistry 2002, 41:1020-1026.
22. Hammel M., Kriechbaum M., Gries A., Kostner G.M., Laggner P., Prassl R. Solution structure of human and bovine beta(2)-glycoprotein I revealed by small-angle X-ray scattering. Journal of Molecular Biology 2002, 321:85-97.
23. Hart M.L., Ceonzo K.A., Shaffer L.A., Takahashi K., Rother R.P., Reenstra W.R., Buras J.A., Stahl G.L. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. Journal of Immunology 2005, 174:6373-6380.
24. Hill J., Lindsay T.F., Ortiz F., Yeh C.G., Hechtman H.B., Moore F.D. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. Journal of Immunology 1992, 149:1723-1728.
25. Kondo A., Miyamoto T., Yonekawa O., Giessing A.M., Osterlund E.C., Jensen O.N. Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome. Journal of Proteomics 2009, 73:123-133.
26. Kulik L., Fleming S.D., Moratz C., Reuter J.W., Novikov A., Chen K., Andrews K.A., Markaryan A., Quigg R.J., Silverman G.J., Tsokos G.C., Holers V.M. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. Journal of Immunology 2009, 182:5363-5373.
27. Laplante P., Amireault P., Subang R., Dieude M., Levine J.S., Rauch J. Interaction of beta2-glycoprotein I with lipopolysaccharide leads to toll-like receptor 4 (TLR4)-dependent activation of macrophages. Journal of Biological Chemistry 2011, 286:42494-42503.
28. Lee N.S., Brewer H.B., Osborne J.C. beta 2-Glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. Journal of Biological Chemistry 1983, 258:4765-4770.
29. Manfredi A.A., Rovere P., Heltai S., Galati G., Nebbia G., Tincani A., Balestrieri G., Sabbadini M.G. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis and Rheumatism 1998, 41:215-223.
30. Martin F., Kearney J.F. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a natural immune memory. Immunological Reviews 2000, 175:70-79.
31. Meroni P.L., Raschi E., Testoni C., Tincani A., Balestrieri G., Molteni R., Khamashta M.A., Tremoli E., Camera M. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis and Rheumatism 2001, 44:2870-2878.
32. Moses T., Wagner L., Fleming S.D. TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. Journal of Leukocyte Biology 2009, 86:971-980.
33. Nilsson M., Wasylik S., Morgelin M., Olin A.I., Meijers J.C., Derksen R.H., de Groot P.G., Herwald H. The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes. Molecular Microbiology 2008, 67:482-492.
34. Pope M.R., Hoffman S.M., Tomlinson S., Fleming S.D. Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Molecular Immunology 2010, 48:356-364.
35. Rehrig S., Fleming S.D., Anderson J., Guthridge J.M., Rakstang J., McQueen C.E., Holers V.M., Tsokos G.C., Shea-Donohue T. Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. Journal of Immunology 2001, 167:5921-5927.
36. Schousboe I. Characterization of subfractions of beta 2-glycoprotein I: evidence for sialic acid microheterogeneity. International Journal of Biochemistry 1983, 15:35-44.
37. Schultze H.E. Glycoproteins of human plasma. Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften 1961, 17:77-91.
38. Schwarzenbacher R., Zeth K., Diederichs K., Gries A., Kostner G.M., Laggner P., Prassl R. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO Journal 1999, 18:6228-6239.
39. Sjogren R.W., Colleton C., Shea-Donohue T.S. Intestinal myoelectric response in two different models of acute enteric inflammation. American Journal of Physiology 1994, 267:G329-G337.
40. Sparkes B.L., Slone E.E., Roth M., Welti R., Fleming S.D. Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion. Biochimica et Biophysica Acta 2010, 1801:517-525.
41. Stefas I., Dubois G., Tigrett S., Lucarz E., Veas F. Apolipoprotein H, an acute phase protein: a performing tool for ultra-sensitive detection and isolation of microorganisms from different origins. InTechWeb 2011, F. Veas (Ed.).
42. Tolomeo T., Rico De Souza A., Roter E., Dieude M., Amireault P., Subang R., Levine J.S., Rauch J. T cells demonstrate a Th1-biased response to native beta2-glycoprotein I in a murine model of anti-phospholipid antibody induction. Autoimmunity 2009, 42:292-295.
43. Weiser M.R., Williams J.P., Moore F.D., Kobzik L., Ma M., Hechtman H.B., Carroll M.C. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. Journal of Experimental Medicine 1996, 183:2343-2348.
44. Williams J.P., Pechet T.T.V., Weiser M.R., Reid R., Kobzik L., Moore F.D., Carroll M.C., Hechtman H.B. Intestinal reperfusion injury is mediated by IgM and complement. Journal of Applied Physiology 1999, 86:938-942.
45. Wurm H. beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. International Journal of Biochemistry 1984, 16:511-515.
46. Zhang M., Austen W.G., Chiu I., Alicot E.M., Humg R., Ma M., Verna N., Xu M., Hechtman H.B., Moore F.D., Carroll M.C. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3886-3891.